Kimia Farma Tbk. (KAEF)
IDX
438.00
-4.00 (-0.90%)
Closed
Aug 24, 2026
Day's Range
436.00442.00
52 wk Range
380.00785.00
Financial Statements - KAEF - Kimia Farma Tbk.
Revenue
9.22T▼ 7.2%
Net Income
-443.35B▲ 63.3%Net Margin -4.8%
EBITDA
293.31B▲ 204.2%
Free Cash Flow
101.02B▲ 554.7%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 9.22T | 9.93T | 9.96T | 9.23T | 12.85T | 10T |
| Cost of Goods | 6.15T | 6.99T | 6.86T | 5.45T | 8.46T | 6.34T |
| Gross Profit | 3.06T | 2.94T | 3.10T | 3.77T | 4.39T | 3.65T |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -171.48B | -844.52B | -1.56T | 337.31B | 910.43B | 529.21B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | -438.08B | -1.22T | -2.16T | -16.39B | 392.88B | 73.35B |
| Income Tax | 5.27B | -21.52B | -365.57B | 94.17B | 102.99B | 52.93B |
| Net Income | -443.35B | -1.20T | -1.82T | -126.02B | 289.88B | 20.42B |
| EPS Basic | -60.17 | -151.31 | -268.64 | -34.25 | 54.42 | 3.18 |
| EPS Diluted | -60.17 | -151.31 | -268.64 | -34.25 | 54.42 | 3.18 |
| Basic Shares Outstanding | 5.56B | 5.56B | 5.56B | 5.56B | 5.55B | 5.55B |
| Diluted Shares Outstanding | 5.56B | 5.56B | 5.56B | 5.56B | 5.55B | 5.55B |
| Ebit | 148.23B | -588.86B | -1.54T | 509.21B | 999.69B | 669.73B |
| Ebitda | 293.31B | -281.55B | -1.11T | 730.66B | 1.22T | 819.45B |
| Net Income Continuous Operations | - | - | - | - | - | - |
| Minority Interests | 108.39B | 365.90B | 335.91B | -64.44B | 12.38B | -2.78B |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
